Search filters

List of works by Evguenia Svarovskaia

Characterization of Hepatitis C virus resistance from a multiple-dose clinical trial of the novel NS5A inhibitor GS-5885.

scientific article published on 22 July 2013

Characterization of hepatitis C virus intergenotypic recombinant strains and associated virological response to sofosbuvir/ribavirin

scientific article published on 15 December 2014

Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials

scientific article published on 5 April 2017

Efficacy of Ledipasvir Plus Sofosbuvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2 Infection

scientific article published on 27 January 2017

Efficacy of ledipasvir and sofosbuvir, with or without ribavirin, for 12 weeks in patients with HCV genotype 3 or 6 infection

scientific article

Efficacy of nucleotide polymerase inhibitor sofosbuvir plus the NS5A inhibitor ledipasvir or the NS5B non-nucleoside inhibitor GS-9669 against HCV genotype 1 infection

scientific article

Efficacy of sofosbuvir plus ribavirin in treatment-naive patients with genotype-1 and -3 HCV infection: results from a Russian Phase IIIb study

scientific article

Efficacy of the Combination of Sofosbuvir, Velpatasvir, and the NS3/4A Protease Inhibitor GS-9857 in Treatment-Naïve or Previously Treated Patients With Hepatitis C Virus Genotype 1 or 3 Infections

scientific article published on 27 May 2016

Genotype- and Subtype-Independent Full-Genome Sequencing Assay for Hepatitis C Virus

scientific article

Global epidemiology of HCV subtypes and resistance-associated substitutions evaluated by sequencing-based subtype analyses

scientific article published on 23 March 2017

Ledipasvir plus sofosbuvir for 12 weeks in patients with hepatitis C genotype 4 infection

scientific article published on 28 June 2016

Ledipasvir-sofosbuvir plus ribavirin for patients with genotype 1 hepatitis C virus previously treated in clinical trials of sofosbuvir regimens

scientific article published on 27 April 2015

Long-term persistence of HCV NS5A resistance associated substitutions after treatment with the HCV NS5A inhibitor, ledipasvir, without sofosbuvir

scientific article

NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: Prevalence and effect on treatment outcome

scientific article published on 17 January 2017

Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C.

scientific article

Resistance Characterization of Ledipasvir and Velpatasvir in Hepatitis C Virus Genotype 4.

scientific article published on 6 October 2017

Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection

scientific article

Sofosbuvir and ribavirin for hepatitis C in patients with HIV coinfection

scientific article published on July 2014

Sofosbuvir and ribavirin in HCV genotypes 2 and 3.

scientific article published on 4 May 2014

Sofosbuvir and ribavirin in adolescents 12-17 years old with hepatitis C virus genotype 2 or 3 infection

scientific article published on 22 May 2017

Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study

scientific article published on 28 September 2014

Sofosbuvir for chronic hepatitis C virus infection genotype 1-4 in patients coinfected with HIV.

scientific article published on April 2015

Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study

scientific article published on 4 February 2015

Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection

scientific article published on June 2017

The safety and effectiveness of ledipasvir-sofosbuvir in adolescents 12-17 years old with hepatitis C virus genotype 1 infection

scientific article published on 20 December 2016

Treatment of a patient with genotype 7 hepatitis C virus infection with sofosbuvir and velpatasvir

scientific article published on 14 May 2016

Paulina is supported by:

About Paulina

Help